J Korean Soc Plast Reconstr Surg.  2009 May;36(3):344-347.

Case Reports of Patients having Intermediate Soft Tissue Tumors

Affiliations
  • 1Department of Plastic and Reconstructive Surgery, College of Medicine, Hanyang University, Seoul, Korea. jtkim@hanyang.ac.kr
  • 2Department of Pathology, College of Medicine, Hanyang University, Seoul, Korea.

Abstract

PURPOSE: Malignant soft tissue tumors, known as sarcomas, are well known to be locally aggressive, frequently metastatic, and highly recurrent. In other hands, intermediate soft tissue tumors often recur locally with adjacent tissue infiltration so the clinical management is difficult as sarcoma. In the present study, we evaluate the clinical course of the intermediate soft tissue tumors and consider the management plan for those.
METHODS
From March, 1998 to April 2008, total 3 patients of intermediate soft tissue tumors underwent operations. A patient with fibrohistiocytic neoplasm, a free flap reconstruction was performed, and he underwent several more operations because of recurrences. Other patients with desmoids-type fibromatosis showed local invasion and adhesion, and one of them underwent reoperation due to local recurrence.
RESULTS
Two of 3 patients underwent recurrences of tumors and reoperations were performed. In case of the other patient with no recurrence, follow-up period was just 5 months, so there may be recurrence of tumor in long term follow-up.
CONCLUSION
The clinical course of intermediate soft tissue tumors shows high recurrence rate. So clinically, intermediate soft tissue tumors should be considered as sarcomas. The successful management requires wide resection, carefully planned reconstruction, and close follow up with radiologic evaluation

Keyword

Soft tissue neoplasms; Fibromatosis; Sarcoma

MeSH Terms

Fibroma
Follow-Up Studies
Free Tissue Flaps
Hand
Humans
Recurrence
Reoperation
Sarcoma
Soft Tissue Neoplasms
Full Text Links
  • JKSPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr